RTIX: Summary for RTI Biologics, Inc. - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 6:48am EST - Canadian Markets open in 2 hours and 42 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Regeneration Technologies Inc. (RTIX)

On Feb 9: 3.29 USD 0.00 (0.00%)

MORE ON RTIX

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

RTI Biologics, Inc. (NGM:RTIX) Delayed quote data

Last Trade:	3.29 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	3.29
Open:	N/A
Bid:	N/A
Ask:	N/A
1y Target Est:	12.00

Day's Range:	N/A - N/A
52wk Range:	2.08 - 5.11
Volume:	0
Avg Vol (3m):	281,424
Market Cap:	179.03M
P/E (ttm):	N/A
EPS (ttm):	-0.21
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Add RTIX to Portfolio

Download Data

HEADLINES

•	RTI Biologics, Inc. Q4 2009 Earnings Call Transcript
	at Seeking Alpha (Tue 2:56pm)

•	RTI BIOLOGICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
	EDGAR Online (Tue 8:44am)

•	RTI Biologics Announces 2009 Year End, Fourth Quarter Results, Estimates 2010 Revenues and EPS
	Business Wire (Tue 8:17am)

•	Q4 2009 RTI Biologics, Inc. Earnings Release - Before Market Open
	CCBN (Tue 7:07am)

•	4-Star Stocks Poised to Pop: RTI Biologics
	at Motley Fool (Mon, Feb 8)

•	RTI Biologics Donates Matrix HD to Treat Young Child with Rare Genetic Skin Condition
	Business Wire (Thu, Jan 28)

•	RTI Biologics Announces 2009 Fourth Quarter and Year End Earnings and Conference Call
	Business Wire (Wed, Jan 20)

•	RTI Biologics Adds Christie Blakely, Michael LaPrade to Leadership Team
	Business Wire (Wed, Jan 13)

•	RTI Biologics Donates Allograft Implants for Children with Physical Disabilities in Kijabe, Kenya
	Business Wire (Wed, Dec 16)

•	4-Star Stocks on the Upswing
	at Motley Fool (Mon, Dec 14)

More Headlines for RTIX...

ANALYST

EPS Est (next year) (Dec-07) :	0.03
EPS Est (in 2 years) (Dec-08) :	0.17
Avg Rec (current)*:	1.7
PEG Ratio:	13.33

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Regeneration Technologies, Inc., together with its subsidiaries, processes human musculoskeletal and other tissue, including bone, cartilage, tendon, ligament, and dermal tissue to produce allografts.

Full Company Profile

Add to Portfolio

Email to a Friend

•